Dominican company based in Santo Domingo · We only ship within the Dominican Republic · No international shippingDominican Republic only · No international shipping
ES Home Catalog Education COAs Calculator Founder
CJC-1295 with DAC
Renova Verification
  • ✓≥99% purity by HPLC + mass spectrometry
  • ✓Independent Janoshik 3rd-party analysis
  • ✓−20°C lyophilized · 2–8°C reconstituted
🧪 View COA →
Home › Products › Growth Hormone › CJC-1295 with DAC
← Back to catalog Growth HormoneAvailable

CJC-1295 with DAC (5 mg)

GHRHDACLong-acting
$210 USD5 mg/vial
🧪 Bacteriostatic water — needed to reconstitute the lyophilized vial
💰 Buy by volume
3+ of one
Save 15%
5+ of one
Save 25%
★ Wholesale
10+ of one
Save 40%
🔀 Mix & Match · across different products: 3+ items 10% · 5+ 15% · 7+ 20%
The best discount per product is applied automatically at checkout (they don't stack). Excludes bacteriostatic water; Retatrutide and Tirzepatide only get same-product volume. Can't be combined with promo codes.
🧪 COA❄️ Cold chain🛡️ Replacement guarantee🔒 Secure payment📦 Nationwide shipping🇺🇸 cGMP · ISO 9001 guidelines · COA

Version with Drug Affinity Complex — half-life of 7-10 days. A single dose maintains elevated GH levels for over a week.

  • Mechanism: GHRH analog with DAC; well-defined GHRH receptor. DAC binds albumin and extends half-life to days.
  • Evidence: Mostly preclinical; small early human trials (Phase 1/2) with sustained GH/IGF-1.
  • In context: GH/IGF-1 are pro-growth (theoretical tumor caution).
Research range · SC
1–2 mg · 1×/week
🟡 Preclinical · long half-life (DAC)

Ranges cited in research literature. Not a usage recommendation. For research use only.

📋 Technical datasheet · Compound specifications
CompoundCJC-1295 with DAC
Origin🇺🇸 From US-based suppliers that follow strict cGMP & ISO 9001 guidelines
FormLyophilized in sterile vial (or pre-mixed solution depending on SKU)
Molecular formulaC165H269N47O46
Molecular weight3647.20 g/mol
Purity≥99% by HPLC + mass spectrometry (Janoshik Analytical)
StorageLyophilized: −20°C to −80°C, dry, dark · Reconstituted: 2–8°C · stability varies by peptide (see the reconstitution guide and the product COA)
Recommended solventBacteriostatic water (0.9% benzyl alcohol) or 0.9% saline
Cold chain2–8°C in transit · controlled thermal packaging
UseResearch Use Only (RUO). Not intended for human or veterinary use.

Typical values for this compound category. For product-specific data, see the corresponding COA at /en/coa/.

This product is exclusively for research purposes. Not intended for human use, consumption, or therapeutic applications. For laboratory use only under qualified supervision.

CJC-1295 with DAC: research profile

CJC-1295 with DAC is an analog of growth-hormone-releasing hormone (GHRH) developed by ConjuChem in the early 2000s. It starts from the active GHRH(1-29) fragment with four substitutions that protect it from enzymatic degradation, and adds at the C-terminus a lysine bearing a maleimidopropionic group: the “Drug Affinity Complex”, or DAC. That group reacts covalently with cysteine 34 of plasma albumin as soon as the peptide enters circulation.

The consequence is a half-life of 6 to 8 days, against the minutes of native GHRH or sermorelin. In the reference human pharmacokinetic study (Teichman et al., Journal of Clinical Endocrinology & Metabolism, 2006), a single administration raised mean GH 2- to 10-fold for six days and IGF-1 1.5- to 3-fold for 9 to 11 days while preserving pulsatility. In other words, it does not replace the pulses; it makes all of them taller.

ConjuChem took the molecule to Phase 2 in GH deficiency and HIV-associated lipodystrophy, but development was halted in 2006 and it never reached approval. Because of its duration it is the GHRH analog under which GH and IGF-1 stay elevated the longest, which sharpens the usual considerations of this axis: fluid retention, effects on glucose and theoretical caution in tumor contexts. Renova distributes it for research only.

CJC-1295 with DAC technical data

ClassLong-acting GHRH(1-29) analog with Drug Affinity Complex
StructureMod GRF(1-29) [D-Ala2, Gln8, Ala15, Leu27] + Lys30-maleimidopropionic acid (DAC)
CAS863288-34-0
Albumin bindingCovalent, to Cys34 of plasma albumin
Reported half-life6–8 days (versus ≈ 30 min without DAC)
Human dataTeichman et al., JCEM 2006: GH ×2–10 for 6 days; IGF-1 ×1.5–3 for 9–11 days
Clinical developmentPhase 2 (ConjuChem) in GH deficiency and HIV lipodystrophy; halted in 2006
Regulatory statusNot approved; GHRH and analogs on the WADA list (S2)

Questions about CJC-1295 with DAC

What is DAC and what does it change versus CJC-1295 without DAC?

DAC (Drug Affinity Complex) is a chemical group added to the end of the peptide that binds permanently to blood albumin. It turns a molecule lasting half an hour into one lasting almost a week. CJC-1295 without DAC (Mod GRF 1-29) is the same sequence without that group, with short, pulsatile action.

Does CJC-1295 with DAC abolish the natural GH pulses?

No, according to the Teichman study (2006): secretion remained pulsatile, but with every pulse taller and an elevated baseline GH for days. The difference from short analogs is the duration of the elevation, not loss of the pattern.

Why was CJC-1295's clinical development halted?

ConjuChem stopped the Phase 2 program in 2006 and the molecule never returned to pivotal trials. Since then it has existed only as a research compound, with well-described pharmacokinetics but no long-term human efficacy or safety data.

When does CJC-1295 with DAC make sense instead of the blend with ipamorelin?

When the research line requires a sustained elevation of GH and IGF-1 with infrequent administration. If the aim is to reproduce physiological pulses with a short half-life, the option is Mod GRF 1-29, alone or with ipamorelin. Our CJC-1295 + Ipamorelin stack guide details the difference.

Related reading: CJC-1295 + Ipamorelin: The Most-Studied GH Stack · Peptide Stacking: Synergy, Sequencing, and Combinations

Informational content based on published scientific literature; it is not a recommendation for use or medical advice. Product strictly for research use (RUO), not suitable for human or veterinary consumption.

Questions? Write us

Your Order

Your cart is empty